Glaxosmithkline Pharmaceuticals informs about details of loss of certificate

13 Mar 2024 Evaluate
Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Glaxosmithkline Pharmaceuticals has informed that Registrar and Transfer Agent of Company KFin Technologies has received request for issue of duplicate Share Certificates from Shareholders. They shall issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder. 

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2082.65 -11.20 (-0.53%)
06-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.